| Patent application number | Description | Published |
|---|
| 20080207722 | Glepp-1 Inhibitors in the Treatment of Autoimmune and/or Inflammatory Disorders - The present invention is related to the use of a Glepp-1 inhibitor for the manufacture of a medicament for the treatment of an autoimmune and/or an inflammatory disorder. | 08-28-2008 |
| 20090018169 | Sulfonamide Derivatives for the Treatment of Bacterial Infections - This present invention is related to sulfonamide derivatives of Formula (I), pharmaceutical composition thereof, methods of preparation thereof and to their use for the treatment and/or prophylaxis of bacterial infections such as tuberculosis. | 01-15-2009 |
| 20090029903 | 1,1'-(1,2-Ethynediyl)Bis-Benzene Derivatives As Ptp 1-B Inhibitors - The present invention is related to carboxylic acids of Formula (I) and use thereof for the treatment and/or prevention of obesity and/or metabolic disorders mediated by insulin resistance or hyperglycemia, comprising diabetes type I and/or II, inadequate glucose tolerance, insulin resistance, hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, polycystic ovary syndrome (PCOS). In particular, the present invention is related to the use of carboxylic acids of Formula (I) to modulate, notably to inhibit the activity of PTPs. | 01-29-2009 |
| 20090221575 | Sulfonamide derivatives and use thereof for the modulation of metalloproteinases - The present invention is related to sulfonamide derivatives of Formula (Ia) | 09-03-2009 |
| 20100210619 | 6-Amino-Pyrimidine-4-Carboxamide Derivatives and Related Compounds Which Bind to the Sphingosine 1-Phosphate (S1P) Receptor for the Treatment of Multiple Sclerosis - The invention relates to compounds of formula (I): | 08-19-2010 |
| 20100240658 | Oxadiazole Derivatives - The invention relates to compounds of formula I: | 09-23-2010 |
| 20100305104 | Oxadiazole Diaryl Compounds - The invention relates to compounds of formula (I): | 12-02-2010 |
| 20110263628 | N-HYDROXYAMIDE DERIVATIVES AND USE THEREOF - The present invention is related to N-hydroxyamide derivatives of Formula (I) and use thereof in particular for the treatment and/or prophylaxis of autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, cancer, respiratory diseases and fibrosis, including multiple sclerosis, arthritis, emphysema, chronic obstructive pulmonary disease, liver and pulmonary fibrosis. | 10-27-2011 |
